Novartis researchers are using new technologies, such as DNA-encoded libraries, to find new ways to treat disease.
Bioengineers, immunologists and clinicians collaborate to explore a new approach to fighting cancer.
Novartis works tirelessly with third-party organizations to improve access to cancer care.
Review the strategy and annual performance of Novartis and read letters from our Chairman and CEO.
This site is intended for a global audience.